Elevated IL-6 levels activate hepatic stellate cells via the JAK/STAT pathway, promote lipid droplet accumulation, and stimulate Kupffer cell responses, playing a key role in the transition from NAFL to NASH (56). Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.